{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:06:21Z","timestamp":1790651181664,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.euroneuro.2019.04.005","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T12:53:01Z","timestamp":1557319981000},"page":"786-794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis"],"prefix":"10.1016","volume":"29","author":[{"given":"Miquel","family":"Bioque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibiana","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9098-655X","authenticated-orcid":false,"given":"Antonio","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gonz\u00e1lez-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Rodriguez-Toscano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iluminada","family":"Corripio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immaculada","family":"Baeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Guti\u00e9rrez","family":"Fraile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel J.","family":"Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Mezquida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Lafuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2019.04.005_bib0026","series-title":"DSM-IV: diagnostic and statistical manual of mental disorders","year":"1994"},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0001","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.schres.2017.01.058","article-title":"Modelling gene-environment interaction in first episodes of psychosis","volume":"189","author":"Bernardo","year":"2017","journal-title":"Schizophr Res"},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.rpsm.2012.11.001","article-title":"Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs)","volume":"6","author":"Bernardo","year":"2013","journal-title":"Rev. Psiquiatr Salud Ment."},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0003","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jpsychires.2016.01.002","article-title":"Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis","volume":"75","author":"Bioque","year":"2016","journal-title":"J. Psychiatr. Res."},{"issue":"13","key":"10.1016\/j.euroneuro.2019.04.005_bib0004","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/npp.2013.165","article-title":"Peripheral endocannabinoid system dysregulation in first-episode psychosis","volume":"38","author":"Bioque","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0005","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.biopsych.2016.04.012","article-title":"Fatty acid amide hydrolase binding in brain of cannabis users: imaging with the novel radiotracer [11C]CURB","volume":"80","author":"Boileau","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0006","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.schres.2015.02.022","article-title":"Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis","volume":"164","author":"Cuesta","year":"2015","journal-title":"The PEPsCog Study. Schizophr Res."},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0007","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jpsychires.2016.12.001","article-title":"Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: evidence for defective immunomodulatory mechanisms","volume":"87","author":"de Campos-Carli","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0008","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-511X-2-5","article-title":"Endocannabinoid signalling in the blood of patients with schizophrenia","volume":"2","author":"De Marchi","year":"2003","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0009","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/npp.2009.166","article-title":"More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine","volume":"35","author":"Dlugos","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0010","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archpsyc.65.7.772","article-title":"Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia","volume":"65","author":"Eggan","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0011","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s12035-016-9697-5","article-title":"Role of the endocannabinoid system in the pathophysiology of schizophrenia","volume":"54","author":"Fakhoury","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0012","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","article-title":"Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms","volume":"29","author":"Giuffrida","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0013","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/bioinformatics\/btm025","article-title":"SNPassoc: an R package to perform whole genome association studies","volume":"23","author":"Gonzalez","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0014","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.biopsych.2009.09.024","article-title":"Brain cannabinoid CB2 receptor in schizophrenia","volume":"67","author":"Ishiguro","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull."},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0016","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000259089","article-title":"EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence","volume":"1","author":"Kokkevi","year":"1995","journal-title":"Eur. Addict Res."},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0017","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0018","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/archgenpsychiatry.2010.6","article-title":"Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults","volume":"67","author":"McGrath","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0019","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1192\/bjp.bp.112.121178","article-title":"Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms","volume":"202","author":"Morgan","year":"2013","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.schres.2013.06.013","article-title":"Quantification of endocannabinoids in postmortem brain of schizophrenic subjects","volume":"148","author":"Muguruza","year":"2013","journal-title":"Schizophr Res."},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0021","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1038\/tp.2012.1","article-title":"Fatty-acid amide hydrolase polymorphisms and post-traumatic stress disorder after penetrating brain injury","volume":"2","author":"Pardini","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0022","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0023","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/schbul\/sbu069","article-title":"Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations","volume":"40","author":"van Os","year":"2014","journal-title":"Schizophr Bull."},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0024","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/sj.npp.1301224","article-title":"Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task","volume":"32","author":"Varvel","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2019.04.005_bib0025","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.neuroimage.2010.04.034","article-title":"Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR","volume":"52","author":"Wong","year":"2011","journal-title":"Neuroimage"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X19302366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X19302366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:52:02Z","timestamp":1760377922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X19302366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0924977X19302366"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2019.04.005","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2019.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}